Skip to main content
Monthly Archives

July 2021

U.S. Senator Chris Van Hollen, Former Biden COVID-19 Senior Advisor Andy Slavitt, Medical Experts and Protect Our Care Debunk Dangerous COVID-19 Disinformation

Watch the Event Here

Washington, D.C. Today, U.S. Senator Chris Van Hollen (D-MD), former Biden administration senior advisor and former Obama Acting CMS Administrator Andy Slavitt, senior scholar at the Johns Hopkins Center for Health Security Dr. Jennifer Nuzzo, and family physician and public health expert Dr. Jeff Huebner joined Defend The Science for a virtual press conference to counter the COVID-19 disinformation that is endangering millions of Americans and discuss the efforts of the Biden administration to put an end to the pandemic. 

With the highly-contagious Delta variant on the rise, unvaccinated people of all ages are becoming seriously ill and dying from the virus as many Republican leaders are actively undermining vaccination efforts and spreading dangerous conspiracy theories. Today’s event follows Tuesday’s hearing by the United States Senate Committee on Health, Education, Labor, and Pensions (HELP), where Republican Senators Rand Paul and Roger Marshall attacked public health experts and repeated conspiracy theories to cover for the Trump Administration’s disastrous handling of the COVID-19 pandemic. 

“As the Delta variant surges, getting vaccinated could mean life or death for many Americans. That’s why we must stop the dangerous disinformation and attacks on our scientists – including Dr. Fauci – that are ultimately threatening Americans’ lives, undermining our public health experts, and inhibiting our nation’s recovery from the pandemic. We’ve got to continue to call out wild accusations and conspiracy theories when we see them and work overtime to deliver the facts to the American people,” said Senator Chris Van Hollen (D-MD).  

“There’s never been a greater time for all of us to pull together. This is exactly what the President is asking the country to do and exactly what he’s trying to do,” said Andy Slavitt, former CMS Administrator and former COVID-19 senior advisor under the Biden administration. “We have a tool that can stop it, and that should give us great comfort. So the people that are getting sick, going to the hospital, and dying in 2021, this is almost entirely preventable.”

“We are in a very, very worrisome phase right now. We have obviously made important strides against this virus, but unfortunately our efforts have slowed and our rollout of vaccines is meeting tremendous amounts of resistance that is setting us back farther than we need to be,” said Dr. Jennifer Nuzzo, DrPH, SM, at the Johns Hopkins Center for Health Security. “The vast majority of anti-vaccination content on the internet stems from 12 personalities who are making a tremendous amount of money off of spreading lies — it’s a more than a $36 million industry. They are making money, but people are dying.”

“We’re at a point in this pandemic, due to the miraculous vaccines that we have, where nearly every death is preventable,” said Dr. Jeff Huebner, MD, a family medicine physician in Madison, WI. “More people will die tragically and we’re not going to be able to get back to our jobs and our schools with the same confidence we would if people were vaccinated.”

“As COVID-19 cases spike across the country, hospitals are once again becoming overwhelmed and Americans are needlessly dying of a now preventable disease,” said Protect Our Care Chair Leslie Dach. “Republicans should be doing everything in their power to get shots in arms and put an end to this crisis, but instead they are spreading disinformation and fueling vaccine hesitancy. We must reverse course, defend the science and ensure that Americans get vaccinated before it’s too late.” 

NEW AD: Protect Our Care Launches Second NJ Ad in Seven-Figure Campaign Featuring Patient Who Needs Action to Lower Drug Prices

“Parth” Is Running on Digital Platforms Statewide

Watch the 30-Second Ad Here

Watch the 15-Second Ad Here

New Jersey — Protect Our Care launched its second digital ad in New Jersey as part of its seven-figure ad campaign about prescription drug prices. The ad features Parth, a patient from New Jersey whose daughter has diabetes. Her family has been forced to put off making vital repairs to her home to ensure her daughter can get the insulin she needs to survive. In the ad, Parth tells her personal story of struggling to afford lifesaving prescriptions and relays the importance of giving Medicare the power to negotiate with drug companies for lower prices for all Americans. 

The ad is part of The Campaign to Reduce Drug Prices, a grassroots and communications campaign calling for comprehensive legislation to lower drug prices. The ad is running on digital platforms, focusing particularly on older New Jerseyans. Protect Our Care will continue to run ads and host events both nationally and in 14 key states, including New Jersey, throughout the summer.

“Parth and her daughter’s story is all too familiar in New Jersey and across the country,” said Protect Our Care Executive Director Brad Woodhouse. “While drug companies spend billions on stock buybacks, raise executive pay, and continue to hike the price of drugs, millions of Americans are forced to choose between affording the medicines they need to survive or paying for essentials. Americans should not have to pay two or three times more for their medicines than people in other countries. It’s time for New Jersey lawmakers to do the right thing and support giving Medicare the power to negotiate for lower drug prices. The time to act is now.”

Script for “Parth” (:30s):

My daughter was diagnosed at age three with type 1 diabetes.

If my daughter doesn’t get insulin she could go into diabetic ketoacidosis which can result in coma or death.

Drug companies keep raising prices of prescription drugs.

We have had to prioritize paying for her medications.

We have a broken tub and we can’t fix it.

That’s just things we don’t do right now.

We have to let Medicare negotiate lower drug prices. It’s time for Congress to act.

Script for “Parth” (:15s):

My daughter was diagnosed with type 1 diabetes.

Drug companies keep raising prices.

We have a broken tub and we can’t fix it.

We have had to prioritize paying for her medications.

We have to let Medicare negotiate lower drug prices.

TODAY: State Elected Officials and Health Care Storytellers Call for Congressional Action to Lower Prescription Drug Prices

***MEDIA ADVISORY FOR WEDNESDAY, JULY 21, 2021***

TODAY: State Elected Officials and Health Care Storytellers Call for Congressional Action to Lower Prescription Drug Prices

Washington, DC — On Wednesday, July 21, state elected officials along with health care advocates and storytellers will join Protect Our Care for events to emphasize the impact of high prescription drug prices and to call for Congress to take action on this urgent issue.

In 2019, House Democrats passed the Lower Drug Costs Now Act (H.R. 3), bold legislation to give Medicare the power to negotiate for lower drug costs — the single most effective measure to bring down drug prices. In April, House Democrats reintroduced this legislation, giving Congress another opportunity to lower prescription drug costs and meet the demands of voters.

This summer, Protect Our Care launched The Campaign to Reduce Drug Prices with an ad running on television nationally and digitally in 12 key states to demonstrate the urgent need for comprehensive legislation to lower drug prices.

WEDNESDAY

NEW HAMPSHIRE

WHO:
State Sen. Tom Sherman
Kayla Montgomery, Planned Parenthood of Northern New England
Heather Stockwell, Rights and DemocracyNH
Stacey Smith, health care advocate

WHERE: Register for the Event Here

WHEN: Wednesday, July 21 at 10:00 AM ET

ARIZONA

WHO:
State Rep. Melody Hernandez
Dr. Gabrielle Goodrick, health care advocate
Angie Taylor, Arizona patient

WHERE: Register for the Event Here

WHEN: Wednesday, July 21, at 1:00 PM ET // 10:00 AM AT

PRESS CALL: U.S. Senator Chris Van Hollen, Former Biden COVID-19 Senior Advisor Andy Slavitt, Dr. Jennifer Nuzzo (Johns Hopkins), Dr. Jeff Huebner, Protect Our Care Will Counter Flood of COVID-19 Disinformation

***MEDIA ADVISORY FOR WEDNESDAY, JULY 21 AT 1:30 PM ET // 12:30 PM CT***

PRESS CALL: U.S. Senator Chris Van Hollen, Former Biden COVID-19 Senior Advisor Andy Slavitt, Dr. Jennifer Nuzzo (Johns Hopkins), Dr. Jeff Huebner, Protect Our Care Will Counter Flood of COVID-19 Disinformation

Washington, D.C. On Wednesday, July 21 at 1:30 PM ET // 12:30 PM CT, U.S. Senator Chris Van Hollen (D-MD), former Obama and Biden administration advisor and former acting CMS Administrator Andy Slavitt, Dr. Jennifer Nuzzo, senior scholar and associate professor at the Johns Hopkins Bloomberg School of Public Health; Dr. Jeff Huebner, a public health expert and family physician from Madison, Wisconsin; and Protect Our Care Chair Leslie Dach will hold a virtual press conference with Defend the Science to counter the disinformation and wacky conspiracy theories that are endangering millions of Americans and discuss the efforts of the Biden administration.

Right now, coordinated disinformation efforts from Republicans like unvaccinated Senator Rand Paul and Congressman Jim Jordan have led to vaccine hesitancy among millions of Americans and causing unnecessary deaths, despite widespread availability of the vaccine. As the Delta variant becomes dominant in the world and thousands of younger, unvaccinated Americans are becoming sick with this new strain of Covid-19, the time is now to end the disinformation that is keeping 37% of American adults unvaccinated. 

At Tuesday’s hearing of the United States Senate Committee on Health, Education, Labor, and Pensions (HELP), Republican Senators Rand Paul and Roger Marshall repeated ridiculous conspiracy theories to cover for the Trump Administration’s disastrous handling of the Covid-19 pandemic. They want to shift blame to public health experts who are leading us out of the crisis, like Dr. Anthony Fauci. In the process, they are threatening the lives of far too many Americans. 

PRESS CALL:

WHO:
U.S. Senator Chris Van Hollen (D-MD)
Andy Slavitt, former Administrator of the Centers for Medicare and Medicaid Services and senior advisor to the White House COVID-19 Response Coordinator
Jennifer Nuzzo, DrPH, SM, Senior Scholar at the Johns Hopkins Center for Health Security, an Associate Professor in the Department of Environmental Health and Engineering and the Department of Epidemiology at the Johns Hopkins Bloomberg School of Public Health, and a Senior Fellow for Global Health at the Council on Foreign Relations.
Jeff Huebner, MD, practicing family physician from Madison, Wisconsin, and Board of Directors, Doctors for America
Leslie Dach, Chair of Protect Our Care

WHAT: Virtual Press Conference to Counter Flood of COVID-19 Disinformation

WHERE: Register for the Event Here

WHEN: Wednesday, July 21 at 1:30 PM ET // 12:30 PM CT

Protect Our Care Announces Nationwide August Bus Tour In Sprint to Expand and Improve Health Care and Lower Costs for the American People

Protect Our Care Announces 19-State Tour In August

Care Force One’s “Lower Cost, Better Care” Bus Tour Will Travel From Maine to California Advocating for Lower Drug Prices and Lower Premiums, Expanded Health Care Coverage and Benefits In the ACA, Medicaid and Medicare 

Washington, D.C. — Throughout the August Congressional recess, Protect Our Care will be running its third nationwide bus tour to demonstrate the urgent need for lowering health costs, expanding coverage, and reducing racial disparities in care. Kicking off in Bangor, Maine, on August 9th, Care Force One’s “Lower Cost, Better Care” bus tour will travel throughout the Northeast before making stops across the Midwest and Southeast, and concluding with stops on the West Coast.   

Care Force One will roll into key districts and states for events with Members of Congress, local elected officials, health care advocates and storytellers to ensure critical health care measures supported by President Biden remain in upcoming budget reconciliation legislation. Specifically, Protect Our Care is fighting to give Medicare the power to negotiate for lower drug prices for all Americans, create a federal solution to close the Medicaid coverage gap, expand Medicare benefits to include vision, dental and hearing, and make permanent the premium reductions included in the American Rescue Plan so millions of people can continue to access low-cost coverage.

The tour will promote the work of President Biden and dozens of Democratic lawmakers who are leading the charge to advance American health care and hold Republicans accountable for continuing to reject measures to improve care and lower costs for the American people. Protect Our Care will ensure Americans know if their elected officials are working for the American people or if they are working to protect health care industry profits. 

“While Members of Congress go home to their districts this August recess, they’re going to have a chance to show their constituents whether they stand by President Biden’s agenda to improve health care for millions or if they side with Big Pharma and other special interests,” said Protect Our Care Executive Director Brad Woodhouse. “Throughout this tour, Americans from all walks of life will speak out about the pressing need to lower prescription drug prices, close the Medicaid coverage gap, expand Medicare benefits to include hearing, dental, and vision, and further reduce health costs for people purchasing coverage on their own. When Congress returns this fall, we have a once in a generation opportunity to transform health care for the American people, and Care Force One will crisscross the country this summer making the case for getting this critical job done.” 

Protect Our Care’s Care Force One will make stops in:
Bangor, Maine on Monday, August 9, 2021
Portland, Maine on Monday, August 9, 2021
Burlington, Vermont on Tuesday, August 10, 2021
Manchester, New Hampshire on Tuesday, August 10, 2021
Concord, New Hampshire on Wednesday, August 11, 2021
Boston, Massachusetts on Wednesday, August 11, 2021
Teaneck, New Jersey on Thursday, August 12, 2021
Allentown, Pennsylvania on Thursday, August 12, 2021
New York, New York on Friday, August 13, 2021
New Brunswick, New Jersey on Monday, August 16, 2021
Scranton, Pennsylvania on Monday, August 16, 2021
Burlington County, New Jersey on Tuesday, August 17, 2021
Wilmington, Delaware on Tuesday, August 17, 2021
Dover, Delaware on Tuesday, August 17, 2021
Morgantown, West Virginia on Wednesday, August 18, 2021
Pittsburgh, Pennsylvania on Wednesday, August 18, 2021
Youngstown, Ohio on Thursday, August 19, 2021
Columbus, Ohio on Thursday, August 19, 2021
Milwaukee, Wisconsin on Friday, August 20, 2021
Madison, Wisconsin on Friday, August 20, 2021
Parkersburg, West Virginia on Monday, August 23, 2021
Charleston, West Virginia on Monday, August 23, 2021
Raleigh, North Carolina on Tuesday, August 24, 2021
Charlotte, North Carolina on Tuesday, August 24, 2021
Columbia, South Carolina on Tuesday, August 24, 2021
Atlanta, Georgia on Wednesday, August 25, 2021
Savannah, Georgia on Wednesday, August 25, 2021
Orlando, Florida on Thursday, August 26, 2021
Tampa, Florida on Thursday, August 26, 2021
Denver, Colorado on Monday, August 30, 2021
Flagstaff, Arizona on Tuesday, August 31, 2021
Phoenix, Arizona on Tuesday, August 31, 2021
Tucson, Arizona on Wednesday, September 1, 2021
San Diego, California on Thursday, September 2, 2021
Anaheim, California on Thursday, September 2, 2021
Las Vegas, Nevada on Friday, September 3, 2021

By the Numbers: What Democratic Health Care Priorities Would Mean for Americans

  • Lowering Prescription Drug Prices. 53 percent of American adults, or roughly 130 million people, take prescription drugs in the U.S. and stand to benefit from legislation to lower drug prices. Allowing Medicare to negotiate drug prices would save patients $158 billion at the pharmacy counter. Nine in 10 Americans support legislation to give Medicare the power to negotiate for lower drug prices. 
  • Closing The Coverage Gap. More than 2 million Americans living in the 12 holdout states would have access to affordable, quality health coverage through Medicaid expansion. People of color make up 60 percent of those living in the health insurance coverage gap.
  • Expanding Coverage. 4.2 million uninsured people would gain coverage if the American Rescue Plan’s subsidies are made permanent, and millions more would continue to save on health care costs. 
  • Expanding Medicare To Include Dental, Vision, and Hearing. Nearly 38 million traditional Medicare enrollees would gain dental, vision, and hearing coverage. Due to lack of coverage, nearly half of Medicare beneficiaries did not seek dental care in the past year, with people of color, individuals with low-incomes, and residents of rural areas experiencing the lowest access. 

NEW REPORT: How High Drug Prices Hurt Small Businesses

Protect Our Care & Small Business for America’s Future Release New Report As Part of Lower Rx Summer

Today, Protect Our Care is kicking off Week 7 of Lower Rx Summer with a report co-sponsored by Small Business for America’s Future underscoring how high drug prices hurt small businesses. Throughout the week, Protect Our Care will host events and release additional research to demonstrate the urgency for drug pricing reform. Lowering drug prices would help small businesses recover from the pandemic and thrive for years to come. 

KEY POINTS:

  • The rising cost of prescription drug prices is crushing small businesses. Nearly one in three small businesses currently providing health benefits to their workers have considered ending their sponsored coverage largely as a result of rising health care costs. 93 percent of small business owners believe the prescription drug market needs to undergo changes, with 66 percent calling for a major overhaul. 
  • Small businesses are forced to pass along the increased costs of providing coverage to customers and workers. Many small businesses report wanting to “do the right thing” when it comes to providing health coverage for their workers. Tragically, that goal is being pushed increasingly out of reach, as many owners are being forced to raise prices on goods and services and/or increase deductibles and premiums in order to continue providing coverage. 
  • Small businesses demand bold action to lower prescription drug prices. Regardless of where they sit on the political spectrum, small business owners want strong government action on this issue, with 87 percent stating it is important for the Biden-Harris administration and Congress to lower prescription medication prices. In a recent survey, small business owners overwhelmingly supported solutions such as capping out-of-pocket costs for seniors, Medicare negotiating drug prices, prohibiting anti-competitive behaviors that delay price competition, and penalizing drug companies that increase their prices faster than inflation. 

“The cost of healthcare and prescription drugs have skyrocketed for many small businesses and it’s having a real impact on their growth,” said Small Business for America’s Future Co-Chair Erika Gonzalez, an Allergy & Asthma Medical Professional and small business owner based in San Antonio. “If we are going to have a strong small business sector and economic recovery, we need our policymakers to act to rein in these costs. It’s an urgent priority of small businesses.”

“The American economy is paying the price for high drug costs,” said Protect Our Care Chair Leslie Dach. “As prescription drug prices skyrocket, small businesses are paying more and more for health care, forcing them to increase costs and lower wages, all while big drug companies are spending billions on stock buybacks and shareholder dividends. The future of small businesses depends on standing up to Big Pharma’s greed and giving Medicare the power to negotiate for lower drug prices.” 

In June, Protect Our Care announced Lower Rx Summer as part of The Campaign to Reduce Drug Prices. Lower Rx Summer consists of themed weeks of action to illustrate the urgent need for legislation to lower drug prices principally by giving Medicare the power to negotiate with drug companies for lower prices for all Americans.

Remaining Theme Weeks for Lower Rx Summer
Week 7 (July 19): How High Drug Prices Hurt Small Businesses
Week 8 (July 26): How High Drug Prices Hurt Children
Week 9 (August 2): Expanding Medicare Benefits—Dental, Vision, And Hearing

Read the new report on how high drug costs hurt small businesses here.

NEW AD: Protect Our Care Launches Second AZ Ad in Seven-Figure Campaign Featuring Patient Who Needs Action To Lower Drug Prices

“Angie” Is Running on Digital Platforms Statewide

Watch the 30-Second Ad Here

Watch the 15-Second Ad Here

Arizona — Protect Our Care recently launched its second digital ad in Arizona as part of a seven-figure ad campaign about prescription drug prices. The ad features Angie, a patient storyteller from Phoenix who has difficulty paying for prescription drugs that keep her alive after a major heart attack. In the ad, Angie tells her personal story of struggling to afford lifesaving prescriptions and relays the importance of giving Medicare the power to negotiate with drug companies for lower prices for all Americans. 

The ad is part of The Campaign to Reduce Drug Prices, a grassroots and communications campaign calling for comprehensive legislation to lower drug prices. The ad is running on digital platforms, focusing particularly on older Arizonans. Protect Our Care will continue to run ads and host events both nationally and in 14 key states, including Arizona, throughout the summer.

“Angie’s story is all too familiar in Arizona and across the country,” said Protect Our Care Executive Director Brad Woodhouse. “While drug companies spend billions on stock buybacks, raise executive pay, and continue to hike the price of drugs, millions of Americans are forced to choose between paying for the medicines they need to live or paying for food or rent. Americans should not have to pay two or three times more for their medicines than people in other countries. It’s time for Arizona lawmakers to do the right thing and support giving Medicare the power to negotiate for lower drug prices. The time to act is now.”

Script for “Angie” (:30s):

I just got out of the hospital with this widowmaker heart attack.

This huge event that is devastating financially for me.

And I just remembered the most important drug that I have to take was over $600 

and I was like, “am I going to have to pay this every single month?”

Families can’t even afford their prescription for life-saving drugs.

We need to lower drug prices for everyone.

Script for “Angie” (:15s):

I just got out of the hospital with this widowmaker heart attack 

and the most important drug that I have to take was over $600 

and I was like, “am I going to have to pay this every single month?”

We need to lower drug prices for everyone.

FACT SHEET: Consumers Would Save Billions Under the Lower Drug Costs Now Act

H.R. 3 Would Save Individual Patients Thousands Of Dollars On Costly Medications 

Giving Medicare the power to negotiate is the single most effective way to bring down drug prices and reduce costs for patients at the pharmacy counter. In addition to saving taxpayers $500 billion, the Democrats’ proposal would reduce the prices for the costliest medications by as much as 55 percent – saving patients an estimated $158 billion. An analysis from the Center for American Progress found that, in addition to saving patients thousands on expensive treatments for conditions like cancer and multiple sclerosis, H.R. 3 would help lower the cost of insulin for some diabetics by more than $700 annually.

The facts speak for themselves — consumers will benefit from drug price negotiations. It is time to put an end to Big Pharma’s fear mongering once and for all. A recent Committee on Oversight and Reform report found that between 2016 and 2020, 14 drug manufacturers spent a whopping $577 billion on stock buybacks and dividends. This figure is $56 billion more than what was spent on research and development over the same period, proving that high drug prices are funding profits, not innovation. 

KEY POINTS:

  • Drug price negotiations will save Americans billions. Drug price negotiations would drastically lower the cost of prescription drugs for consumers. Analyses confirm empowering the federal government to negotiate would reduce negotiated drug prices for the costliest medications by as much as 55 percent – saving patients an estimated $158 billion
  • Patients are at the whim of Big Pharma. Under our current system, patients are completely at the mercy of pharmaceutical corporations, with nearly one in four Americans taking prescription drugs experiencing difficulty affording their medications.
  • The vast majority of Americans support drug price negotiations. More than eight in ten Americans support the federal government negotiating lower prescription drug prices for Medicare recipients.

Negotiations Are Good For Consumers. The Lower Drug Costs Now Act (H.R. 3), would dramatically reduce the cost of prescription medications by empowering the federal government to negotiate prescription drug prices. Analyses from the nonpartisan Congressional Budget Office and the CMS Office of the Actuary confirmed the bill would reduce negotiated drug prices by as much as 55% – saving patients an estimated $158 billion over the next several years.

Americans Demand Negotiations Now. 79 percent of Americans say the cost of prescription drugs is “unreasonable”, with a recent Harvard-POLITICO poll finding 87 percent of respondents found drug pricing reform to be “extremely important”. When it comes to empowering the federal government to negotiate lower prescription drug prices for Medicare recipients, 86 percent of Americans are in support.

Nearly One In Four Americans Have Difficulty Affording A Prescribed Medication. Nearly one in four Americans taking prescription drugs have difficulty affording their medications, with 29 percent reporting not taking their medicines as prescribed at some point in the past year because of the cost. Those most severely impacted make less than $40,000 a year and have medication costs over $100.

Americans Live In Fear Of Drug Price Increases. Nearly nine in ten Americans feared that drug companies would use the pandemic as an excuse to raise prices. With seemingly endless price increases and drug manufacturers putting profits over people, it’s no wonder three in four Americans don’t trust Big Pharma to do the right thing and set fair prices for prescription drugs. 

High Prescription Drug Prices Perpetuate Racial Disparities. On average, Black, Hispanic, and Latino Medicare beneficiaries without drug coverage use 10 to 40 percent fewer prescription drugs than their white counterparts being treated for the same health issues. Inability to afford needed drugs is likely a critical element in why Black individuals suffer from many chronic illnesses at a greater level of severity. A prescription price increase of just $10 can result in reduced ability to access prescription drugs, often with fatal consequences.

Patient Assistance Programs Are Inaccessible For Those Most In Need. Many pharmaceutical corporations fund independent drug assistance programs. These deceptive programs function under the guise of providing needed medications, but in reality, tend to cover expensive, brand name drugs, even when cost-effective generic alternatives are available. Even more shocking is that 97 percent refused assistance to those who needed it most, individuals without insurance.

NEW REPORT: How High Drug Prices Hurt American Indians and Alaska Natives

Protect Our Care Releases New Report As Part of Lower Rx Summer

Today, Protect Our Care is continuing Week 6 of Lower Rx Summer with a report underscoring how high drug costs hurt American Indians and Alaska Natives. Earlier this week, Protect Our Care published research on the toll that high drug prices take on Black Americans and Hispanic and Latino people. Racial disparities in medication access only demonstrates the urgency for reform to bring down drug prices.

In June, Protect Our Care announced Lower Rx Summer as part of The Campaign to Reduce Drug Prices. Lower Rx Summer consists of themed weeks of action to illustrate the urgent need for legislation to lower drug prices principally by giving Medicare the power to negotiate with drug companies for lower prices for all Americans.

Remaining Theme Weeks for Lower Rx Summer

Week 6 (July 12): How High Drug Prices Hurt People of Color

Week 7 (July 19): How High Drug Prices Hurt Small Businesses

Week 8 (July 26): How High Drug Prices Hurt Children

Week 9 (August 2): Expanding Medicare Benefits—Hearing, Vision, And Dental

Racial inequity penetrates every corner of the American health care system, and high prescription drug prices are no exception. Nearly 30 percent of individuals taking prescription medications struggle to afford the cost, with the burden most severely impacting those who make less than $40,000 a year and have medication costs over $100. These factors disproportionately impact American Indians and Alaska Natives, who are more likely to require medications for chronic health conditions, while simultaneously earning household median incomes nearly $30,000 less than white counterparts, resulting in reduced ability to pay at the pharmacy counter. In addition, many American Indians and Alaska Natives live in one of the 13 states yet to implement Medicaid expansion, with people of color comprising 60 percent of individuals living in the coverage gap. 

“Structural racism has led to American Indians and Alaska Natives being disproportionately burdened by both high drug prices and wealth inequality in the United States,” said Protect Our Care Chair Leslie Dach. “It is unacceptable that millions of people can’t afford the drugs they need to survive. Bringing down the cost of drugs is an essential step in addressing racial inequities in health care. It’s time to put an end to Big Pharma’s greed and give Medicare the power to negotiate for lower drug prices.”

In 2019, the House of Representatives passed the Lower Drug Costs Now Act (H.R. 3), historic legislation that would lower drug prices for all Americans. H.R. 3 would save patients over $150 billion and reduce the price of the costliest drugs by as much as 55 percent

Not only does giving Medicare the power to negotiate help patients at the pharmacy counter, but it would save the federal government $500 billion, which could be reinvested to strengthen health care. These savings could help lower premiums, expand coverage, and strengthen Medicare benefits to include hearing, vision, and dental. As the nation recovers from the coronavirus pandemic, ensuring access to affordable health care, and specifically prescription drugs, has never been more critical. 

KEY POINTS

  • American Indians and Alaska Natives are disproportionately harmed by income and health inequity. American Indians and Alaska Natives are more likely to have a lower median income compared with their white counterparts. This disparity has profound impacts on health outcomes for American Indians and Alaska Natives that can result in reduced ability to access lifesaving drugs and a decrease in life expectancy.
  • American Indians and Alaska Natives are regularly forced to navigate chronic health conditions with reduced access to needed drugs. Compounding social, economic, and political forces make American Indians and Alaska Natives more likely to suffer from ongoing health issues and be faced with outrageous medication prices. Inequitable drug access due to cost creates additional medical problems that disproportionately impact American Indians and Alaska Natives. 
  • Drug pricing reform is crucial to addressing racial health disparities. American Indians and Alaska Natives are significantly more likely to be uninsured than their white counterparts, pushing up the cost of prescription drugs in a country that is already paying nearly three times what individuals in other countries are spending on the same drugs. Wealth and health disparities perpetuated by systemic racism increase the strain of drug costs for American Indians and Alaska Natives.

Read the new report on how high drug costs hurt American Indians and Alaska Natives here.

HEADLINES: Two Million Americans Gain Coverage During President Biden’s Special Enrollment Period

Yesterday, the Department of Health and Human Services announced that two million Americans have signed up for insurance through the Affordable Care Act (ACA) marketplaces during President Biden’s special enrollment period. The Biden administration opened the SEP to ensure people could get coverage as they faced economic hardship and job loss as a result of the coronavirus pandemic. Importantly, many of the new enrollees have been able to take advantage of the dramatic savings under the American Rescue Plan, with more than a third of new and returning enrollees selecting plans for $10 or less per month. Coverage of this historic enrollment period makes it clear that the wave of signups are a direct result of the American Rescue Plan’s provisions to dramatically reduce premiums costs. 

HEADLINES:

The Hill: More Than 2 Million Sign Up During Obamacare Special Enrollment Period. “A total of 1.5 million Americans have enrolled in coverage through HealthCare.gov throughout the special signup period, while another 600,000 have signed up through the 15 state-based marketplaces, the Department of Health and Human Services (HHS) announced.” [7/14/21]

New York Times: Obamacare Enrollments Have Risen By 2 Million, Reaching A Record High, Since Biden Reopened Them In February. “The increases reflect a growing demand for insurance coverage during the pandemic, when many Americans lost job-based coverage or became more worried about remaining uninsured. But they also reflect major policy changes this year: Congress passed legislation that substantially lowered the price of insurance for nearly all Americans buying their own coverage.” [7/14/21]

HuffPost: Obamacare Marketplace Sign-Ups Pass 2 Million, Likely Pushing Down Uninsured Rate. “That figure means total marketplace enrollment is probably at an all-time high, while the number of uninsured Americans may be at an all-time low. In both cases, a big reason would be a set of temporary improvements to the Affordable Care Act that Biden and Democrats are now trying to make permanent.” [7/14/21]

Roll Call: HHS 2 Million People Choose Health Plans During Enrollment Period. “Centers for Medicare and Medicaid Services Administrator Chiquita Brooks-LaSure told reporters the agency doesn’t have updated numbers of the total number of people enrolled in marketplace plans, but she called it a “fair assumption” that marketplace enrollment is at an all-time high.” [7/14/21]

CNN: More Than 2 Million Americans Sign Up For Affordable Care Act Coverage Under Biden’s Special Enrollment Period. “Some 1.5 million people have signed up on the federal exchange, healthcare.gov, while more than 600,000 have selected policies in the 14 states and the District of Columbia that run their own exchanges. In addition, among new and returning consumers who have selected a plan since April 1, some 1.2 million, or 34%, picked policies that cost $10 or less per month when factoring in the enhanced premium subsidies made available by the Democrats’ $1.9 trillion American Rescue Plan. About 2.5 million enrollees have returned to the exchange to see what’s available.” [7/14/21]

Reuters: Over Two Million Americans Sign Up For Obamacare Under Biden Drive. “About 1.5 million Americans opted to sign up for insurance on U.S. government website Healthcare.gov while 600,000 more enrolled in coverage through the 15 state-based marketplaces.” [7/14/21]

Becker’s Hospital Review: ACA Special Enrollment Exceeds 2 Million. “The majority of enrollees used healthcare.gov (1.5 million) while the rest (600,000) used a state marketplace. Both numbers are sure to grow as the SEP spans through Aug. 15, but Medicaid and Children’s Health Insurance Program membership are at a record-high 81 million.” [7/14/21]

MSNBC (Maddow Blog): Biden’s ACA Special Enrollment Period Reaches 2 Million Americans. “Some will see their premiums cut in half, while millions will see their premiums fall to literally zero, thanks entirely to the investments in the American Rescue Plan. That’s working well, too: the Department of Health and Human Services recently announced that after the new ACA benefits kicked in on April 1, nearly 2 million consumers — who already had coverage — returned to the marketplace and reduced their monthly premiums.” [7/14/21]